Psoriasis
📧 Sign up to get email alerts when something new happens for Psoriasis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-03-03Clinical Trial Update: Clinical Utility Of Genetic Screening For HLA-B*1301, On Susceptibility To Dapsone Hypersensitivity Syndrome [Phase 4]
Phase 4 study assessing whether genetic screening for HLA-B*1301 can predict susceptibility to dapsone hypersensitivity syndrome.
-
CLINICAL_TRIALS trial_result · 2017-02-20Clinical Trial Update: Use of Localized NB-UVB (Levia®) in the Treatment of Plaque-psoriasis [NA]
Completed clinical trial evaluating localized narrowband UV-B phototherapy (Levia) for plaque psoriasis; results posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-02-15Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of Efalizumab in Adult Patients With Plaque Psoriasis Involving the Hands and/or Feet [Phase 4]
A completed Phase 4 clinical trial evaluating the safety and efficacy of efalizumab (Raptiva) in adult patients with plaque psoriasis involv…
-
CLINICAL_TRIALS trial_result · 2017-02-09Clinical Trial Update: First Human Dose Study of Anti-IL-20 in Psoriasis: A Study of Safety, Tolerability and Early Signals of Biologic and Clinical Effects [Phase 1]
This Phase 1 first-in-human study of an anti-IL-20 therapy for psoriasis evaluated safety and tolerability with early biological and clinica…
-
CLINICAL_TRIALS trial_result · 2017-02-06Clinical Trial Update: A Study of Topical Indigo Naturalis Treatment in Patients With Mild to Moderate Plaque-type Psoriasis [Phase 2]
This document reports the completion of a Phase 2 trial evaluating topical Indigo Naturalis for mild to moderate plaque-type psoriasis.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-01-19Clinical Trial Update: Multiple Ascending Dose Trial of MSB0010841 (Anti-IL17A/F Nanobody) in Psoriasis Subjects [Phase 1]
A Phase 1 multiple ascending dose trial of MSB0010841, an anti-IL17A/F nanobody, in psoriasis subjects has completed and results were posted…
-
CLINICAL_TRIALS trial_result · 2017-01-11Clinical Trial Update: Comparison of Cathelicidin Expression in Skin and Saliva in Patients With Atopic Dermatitis and Psoriasis
This clinical trial update describes a study comparing cathelicidin expression in skin and saliva of patients with atopic dermatitis and pso…
-
CLINICAL_TRIALS trial_result · 2016-12-30Clinical Trial Update: Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 827 in Subjects With Psoriasis [Phase 2]
Phase 2 clinical trial evaluating safety, tolerability, and efficacy of AMG 827 in psoriasis has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2016-12-28Clinical Trial Update: Patient Insights Following Use of LEO 90100 Aerosol Foam and Daivobet® Gel in Subjects With Psoriasis Vulgaris [Phase 3]
A Phase 3 clinical trial evaluating LEO 90100 Aerosol Foam and Daivobet Gel in psoriasis vulgaris has completed, with results posted.
-
CLINICAL_TRIALS trial_result · 2016-12-28Clinical Trial Update: Safety Study of BMS-986165 in Healthy Subjects and to Treat Psoriasis [Phase 1]
This document reports the completion of a Phase 1 safety study of BMS-986165 in healthy subjects and in patients with psoriasis.
-
CLINICAL_TRIALS trial_result · 2016-12-26Clinical Trial Update: Cardiovascular Effects in Psoriasis Patients Treated With Adalimumab. [NA]
The trial evaluated cardiovascular effects of adalimumab in psoriasis patients; results have been posted.
-
CLINICAL_TRIALS trial_result · 2016-12-22Clinical Trial Update: Study of the Effects of the Organism on Monomethyl Fumarate (MMF) After the Administration of LAS41008 [Phase 1]
A Phase 1 trial in psoriasis examined how LAS41008 interacts with Monomethyl Fumarate (MMF); the study has completed.
-
CLINICAL_TRIALS trial_result · 2016-12-02Clinical Trial Update: An Observational Monocentric Study Investigating the Association Between Trough Serum Levels of Etanercept, Antibodies Towards Etanercept and Its Effectiveness in Psoriasis Patients
This completed observational study examines whether trough serum levels of etanercept and antibodies against etanercept correlate with its e…
-
CLINICAL_TRIALS trial_result · 2016-11-21Clinical Trial Update: Efalizumab for Treatment of Patients With Moderate to Severe Psoriasis [Phase 3]
A Phase 3 trial evaluating efalizumab for moderate to severe psoriasis has completed.
-
CLINICAL_TRIALS trial_result · 2016-11-16Clinical Trial Update: Single Rising Dose Study of BI 655066 in Patients With Moderate and Severe Psoriasis [Phase 1]
AbbVie has completed a Phase 1 single rising dose study of BI 655066 in adults with moderate-to-severe psoriasis. The report focuses on tria…
-
CLINICAL_TRIALS trial_result · 2016-11-15Clinical Trial Update: Microneedle Patch for Psoriatic Plaques [NA]
A clinical trial update from The Catholic University of Korea regarding a microneedle patch for psoriatic plaques; the trial status is unkno…
-
CLINICAL_TRIALS trial_result · 2016-10-27Clinical Trial Update: A Study of Ixekizumab in Participants With Active Psoriatic Arthritis [Phase 3]
Phase 3 clinical trial update for ixekizumab in active psoriatic arthritis; trial completed with results posted in 2016.
-
CLINICAL_TRIALS trial_result · 2016-10-26Clinical Trial Update: T and B Cell Responses in Autoimmune Diseases
A clinical trial evaluating T and B cell responses in autoimmune diseases has been terminated. The update notes the study status and partici…
-
CLINICAL_TRIALS trial_result · 2016-10-26Clinical Trial Update: Psychiatric Problems in Chronic Skin Diseases
A clinical trial examining psychiatric problems in chronic skin diseases has completed, with the study covering psoriasis, acne vulgaris, vi…
-
CLINICAL_TRIALS trial_result · 2016-10-21Clinical Trial Update: A Study of the Early Activity of Ixekizumab (LY2439821) in Moderate-to-Severe Psoriasis [Phase 3]
Phase 3 study assessing early activity of ixekizumab in moderate-to-severe psoriasis completed with posted results.
-
CLINICAL_TRIALS trial_result · 2016-10-21Clinical Trial Update: A Study in Participants With Moderate to Severe Psoriasis (UNCOVER-3) [Phase 3]
A Phase 3 trial updating results for moderate-to-severe psoriasis (UNCOVER-3) completed with results posted in 2016.
-
CLINICAL_TRIALS trial_result · 2016-10-21Clinical Trial Update: BE Study in Patients - Methotrexate Tablets [Phase 1]
Phase 1 bioequivalence study update for methotrexate tablets in psoriasis and rheumatoid arthritis.
-
CLINICAL_TRIALS trial_result · 2016-10-20Clinical Trial Update: A Phase 3 Study in Participants With Moderate to Severe Psoriasis (UNCOVER-2) [Phase 3]
Phase 3 study (UNCOVER-2) in moderate to severe psoriasis completed; results posted in 2016.
-
CLINICAL_TRIALS trial_result · 2016-10-19Clinical Trial Update: Premature Coronary Artery Disease (CAD) in Severe Psoriasis
A clinical trial investigating premature coronary artery disease in people with severe psoriasis has completed. The study was sponsored by t…
-
CLINICAL_TRIALS trial_result · 2016-10-06Clinical Trial Update: A Comparison of DFD01 Spray Versus Comp01 Lotion, Vehicle Spray and Vehicle Lotion in Subjects With Moderate Psoriasis [Phase 3]
Phase 3 trial comparing DFD01 spray to Comp01 lotion and vehicles in adults with moderate psoriasis; study completed with results posted.